Noradrenaline hyperalgesia is mediated through interaction with sympathetic postgahglionic neurone terminals rather than activation of primary afferent nociceptors

Nature

Volumn 323, Issue 6084, 1986, Pages 158-160

  Levine, Jon D ^a,b   Taiwo, Yetunde O ^a   Collins, Stephen D ^a   Tam, Judy K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CHLOROFORM; INDOMETACIN; NORADRENALIN; PHENTOLAMINE; PROSTAGLANDIN E; GUANETHIDINE; OXIDOPAMINE; PRAZOSIN; PROSTAGLANDIN E2; YOHIMBINE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; HYPERALGESIA; HYPERESTHESIA; MALE; NOCICEPTIVE RECEPTOR; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTGANGLIONIC NERVE; RAT; RAT STRAIN; SYMPATHECTOMY; ANIMAL EXPERIMENT; AUTONOMIC NERVOUS SYSTEM; DRUG DOSE; DRUG EFFICACY; DRUG INTERACTION; DRUG MECHANISM; INFLAMMATION; INTRADERMAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; METHODOLOGY; NERVOUS SYSTEM; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SYMPATHETIC NERVE;

ANIMAL; AUTONOMIC FIBERS, POSTGANGLIONIC; BRADYKININ; CHLOROFORM; HYPERALGESIA; HYPERESTHESIA; INDOMETHACIN; MALE; MODELS, NEUROLOGICAL; NOCICEPTORS; NOREPINEPHRINE; PHENTOLAMINE; PROSTAGLANDINS E; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SYMPATHECTOMY;

ANIMALIA;

EID: 0023046987     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/323158a0     Document Type: Article

References (18)

1. Wiesenfeld-Hallin, Z. & Hallin, R. G. Hum. Neurobiol. 3, 41-46 (1984).
2. Loh, L. & Nathan, P. W. J. Neurol. Neurosurg. Psychiat. 41, 664-671 (1978).
3. Wall, P. D. & Gutnick, M. Expl Neurol. 43, 580-593 (1974).
4. Devor, M. & Janig, W. Neurosci. Leu. 24, 43-47 (1981).
5. Devor, M. J. Autonom. Nerv. Sys. 7, 371-384 (1983).
6. Blumberg, H. & Janig, W. Pain 20, 335-354 (1984).
7. Randall, L. O. & Selitto, J. J. Arch. Int. Pharmacodyn. 3, 409-419 (1957).
8. Fitzgerald, M. J. T., Folan, J. C. & O’Brien, T. M. J. invest. Dermat. 64, 169-174 (1975).
9. Bumstock, G., Evans, B., Gannon, B. J., Heath, J. W. & James, V. Br. J. Pharmac. 43, 295-301 (1971).
10. Finch, L., Haeusler, G. & Thoenen, H. Br. J. Pharmac. 47, 249-260 (1973).
11. Starke, K., Wagner, J. & Schumann, H. J. Arch. Int. Pharmacodyn. 195, 291-308 (1977).
12. Stjame, L. Acta physiol scand. 86, 574-576 (1972).
13. Ramwell, P. W., Shaw, J. E. & Kucharski, J. Science 149, 1390-1391 (1965).
14. Westfall, T. C. PhysioL Rev. 57, 659-728 (1977).
15. Juan, H. & Lembeck, F. Agents Actions 6, 642-645 (1976).
16. Wallin, B. G., Torebjork, E. & Hallin, R. G. in Sensory Functions of the Skin of Primates with Special Reference to Man (ed. Zotterman, Y.) 489-499 (Pergamon, Oxford, 1976).
17. Ferreira, S. H., Nakamura, M. & Castro, M. Prostaglandins 16, 31-37 (1978).
18. Devor, M. Pain 22, 127-137 (1985).